Acute bronchitis: topical issues of epidemiology, etiology, pharmacotherapy and prevention


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review is devoted to the issues of epidemiology, pharmacotherapy and prevention of acute bronchitis (AB) in adults. The data on the prevalence of the disease in different countries, modern ideas about the etiology of the AB, directions of pharmacotherapy are given. It is emphasized that AB is a disease of predominantly viral etiology, and the use of antimicrobial drugs in initial treatment regimens is wrong. A critical analysis of the use of various drugs for the treatment of AB from the standpoint of evidence-based medicine, including the possibility of antiviral therapy, as well as recommendations for vaccination is presented.

Full Text

Restricted Access

About the authors

A. A Zaitsev

Academician N.N. Burdenko Main Military Clinical Hospital, Ministry of Defense of the Russian Federation

Email: a-zaicev@yandex.ru
MD, Principal Pulmonologist Moscow, Russia

Kin V.G. Akim

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: vgakimkin@yandex.ru
MD, Academician of the Russian Academy of Sciences, Director Moscow, Russia

References

  1. Bartlett J., Dowell S., Mandell L. et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin. Infect. Dis. 2000; 31: 347-82.
  2. Wenzel R., Fowler A. Acute Bronchitis. Clinical practice. N. Engl. J. Med. 2006; 355: 2125-30.
  3. Albert R. Diagnosis and treatment of acute bronchitis. Am. Fam. Physician 2010; 82(11): 1345-50.
  4. Зайцев А.А. Острый бронхит: диагностика и лечение. Терапия 2017; (1): 31-5.
  5. Worrall G. Acute bronchitis. Can. Fam. Physician 2008; 54 (2): 238-9.
  6. Knutson D., Braun C. Diagnosis and management of acute bronchitis. Am. Fam. Physician 2002; 65(10): 2039-44.
  7. Renati S., Linder J. Necessity of office visits for acute respiratory infections in primary care. Fam Pract. 2016; 33(3): 312-7.
  8. Wark P. Bronchitis (acute). BMJ Clin. Evid. 2015; (7): 1508. https://www. ncbi.nlm.nih.gov/pmc/articles/PMC4505629/
  9. Meza R.A., Bridges-Webb C., Sayer G.P., Miles D.A., Traynor V., Neary S. The management of acute bronchitis in general practice: results from the Australian morbidity and treatment survey. Aust. Fam. Physician 1994: 23: 1550-3.
  10. Li X., Li J., Meng L. et al. Viral etiologies and epidemiology of patients with acute respiratory infections based on sentinel hospitals in Gansu Province, Northwest China 2011-2015. J. Med. Virol. 2018; 90(5): 828-35.
  11. Munoz F., Carvalho M. Effect of exposure time to PM (10) on emergency admissions for acute bronchitis. Cad. Saude Publica 2009; 25(3): 529-39.
  12. Ott S., Rohde G., Lepper P., Hauptmeier B., Bals R., Pletz M.W.R. et al. The impact of viruses in lower respiratory tract infections of the adult. Part II: acute bronchitis, acute exacerbated COPD, pneumonia, and influenza. Pneumologie 2010; 64(1): 18-27.
  13. Wadowsky R., Castilla E., Laus S., Kozy A., Atchison R.W., Kingsley L.A. et al. Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J. Clin. Microbiol. 2002; 40: 637-40.
  14. Meili M., Kutz A., Briel M. et al. Infection biomarkers in primary care patients with acute respiratory tract infections-comparison of Procalcitonin and C-reactive protein. BMC Pulm. Med. 2016; 16: 43. https://www.ncbi. nlm.nih.gov/pubmed/27009083
  15. Зайцев А.А., Овчинников Ю.В., Кондратьева Т.В. Биологические маркеры воспаления при внебольничной пневмонии. Consilium Medicum 2014; 16(11): 36-41.
  16. Franck A., Smith R. Antibiotic use for acute upper respiratory tract infections in a veteran population. J. Am. Pharm. Assoc. 2010; 50(6): 726-9.
  17. Smith S., Fahey T., Smucny J., Becker L. Antibiotics for acute bronchitis. Cochrane Database Syst. Rev. 2014; 1(3): CD000245. doi: 10.1002/14651858.CD000245.pub3.
  18. Зайцев А.А., Кулагина И.Ц. Фармакотерапия острого бронхита. Consilium Medicum 2012; 14(11): 16-21.
  19. Lior C., Moragas A., Bayona C., Morros R., Pera H., Cots J., Fernandez Y., Miravitlles M., Boada A. Effectiveness of antiinflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol. BMC Pulm. Med. 2011; 11: 38-47.
  20. Smucny J., Fahey T., Becker L., Glazier R., McIsaac W. Antibiotics for acute bronchitis. Cochrane Database Syst. Rev. 2000; (4): CD000245.
  21. Barlett J. Respiratory Tract Infections. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
  22. Zaitsev A.A., Kulagina I.C. Pharmacotherapy of acute bronchitis in clinics: results of pharmacoepidemical research. Value in Health 2012; 15(7): A386.
  23. Зайцев А.А., Горелов А.В., Клочков О.И. Острые респираторные вирусные инфекции: перспективы противовирусной терапии. Вестник семейной медицины 2009; (5): 18.
  24. Jefferson T., Tyrrell D. Antivirals for the common cold. The Cochrane Database Syst. Rev. 2005; (3): CD002743.
  25. Зайцев А.А., Кулагина И.Ц., Передельский С.В., Алпенидзе Д.Н. Современные возможности фармакотерапии острого бронхита. Военно-медицинский журнал 2011; 10 (332): 39-44.
  26. Малышев Н.А., Колобухина Л.В., Меркулова Л.Н., Ершов Ф.И. Современные подходы к повышению эффективности терапии и профилактики гриппа и других острых респираторных вирусных инфекций. Consilium Medicum 2005; 10(7): 831-5.
  27. Зайцев А.А., Синопальников А.И. Рациональная фармакотерапия острых респираторных вирусных инфекций. Consilium Medicum 2008; 10(10): 80-6.
  28. Зайцев А.А., Оковитый С.В. Кашель: дифференциальная диагностика и фармакотерапия. Терапевтический архив 2014; (12): 85-91.
  29. Smucny J., Flynn C., Becker L., Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst. Rev. 2004; (1): CD001726.
  30. Зайцев А.А. Направления фармакотерапии и профилактики острых респираторных вирусных инфекций. Русский медицинский журнал 2009; 17(23): 1525-9.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies